HELX241115C26000
- 0.00
- 0.000.00%
Franklin Genomic Advancements Etf Newsroom
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
What the Options Market Tells Us About Danaher
Large Pharmas, Biotechs Down as Industries Grapple With RFK Jr. at HHS
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Market Falls Friday After Light Earnings and 13F's | Live Stock
Moderna Continues to Be the Most Shorted Among S&P 500 Healthcare Stocks in October
Check Out What Whales Are Doing With REGN
Least Shorted S&P 500 Stocks in October
DiamondRock Hospitality Acquires the AC Hotel Minneapolis Downtown
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
What kind of company is Natera, the largest hold positions of Drew Miller?
Currently, there is a lack of precision in adjuvant therapy plans after tumor (MRD) surgery, while MRD testing can detect molecular abnormalities originating from the tumor, enabling early detection of cancer recurrence and guiding precise postoperative treatment. Huayuan Securities believes that natera's MRD testing business has significant competitive advantages, and its launched Signatera product is expected to become the core driving force behind the company's rapid performance improvement.
Regeneron, Sanofi Say Resubmitted Application to Expand Dupixent Label Accepted in U.S.
Wolfe Research Initiates Coverage On Eli Lilly With Outperform Rating, Announces Price Target of $1000
Eli Lilly Analyst Ratings
Top Institutions Continue to Hold Strong Tech Positions in Q3 13F Filings
Mounjaro-Maker Eli Lilly Files Lawsuit Against US Agency Over Drug Rebate Program
Druckenmiller made significant adjustments in the third quarter: opened positions in Bank of America and Broadcom, continued to increase holdings in the top position Natera.
Natera's position significantly increased by 80.61% compared to the previous quarter. Druckenmiller also established new positions in Broadcom, banks, and pharmaceutical stocks, while completely liquidating News Corp and telecom company Liberty Global, and reducing shareholding in microsoft.